Skip to content
Screener

Apyx Medical Corporation APYX Q1 2026 earnings

Reported May 7, 2026 · Before market open

Revenue$12.5MBeat by $2.0M
EPS-$0.05Beat by $0.06
Revenue estimate$10.5M
EPS estimate-$0.11

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$13.3M
EPS estimate-$0.07

Financials

Q1 2026

Income statement

See full
Revenue$12.5M+32.4%
Net income-$2.1M+48.6%

Balance sheet

See full
Cash & equivalents$31.1M+0.4%
Total debt$39.5M+1.4%
Total equity$12.8M+22.1%
Total assets$63.0M+4.8%

Cash flow

See full
Operating cash flow-$572.0K+18.5%
CapEx$60.0K+9.1%
Free cash flow-$632.0K+16.5%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$154.35M+198%
Enterprise value$162.67M+173%
P/S2.8×+1.7×

Profitability

See full
Net margin-16.2%-6.2pp
FCF margin-16.1%-4.8pp

Returns & leverage

See full
Return on equity-77.8%-22.4pp
Debt / equity3.1×-0.6×
Current ratio5.8×+0.3×

Segments

By segment

See full
Oem$1.8M+13.8%

FAQ

When did Apyx Medical Corporation report Q1 2026 earnings?
Apyx Medical Corporation (APYX) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Apyx Medical Corporation's Q1 2026 revenue and EPS?
Apyx Medical Corporation reported revenue of $12.5M and eps of $-0.05 for Q1 2026.
Did Apyx Medical Corporation beat estimates in Q1 2026?
Revenue beat the consensus estimate of $10.5M by $2.0M. EPS beat the consensus estimate of $-0.11 by $0.06.
How did Apyx Medical Corporation's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 32.4% from $9.4M a year earlier and eps grew 50.0% from $-0.10.
Where can I find Apyx Medical Corporation's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001437749-26-015352) and the 10-Q periodic report (0001437749-26-015652) directly on SEC EDGAR. The filing index links above go to sec.gov.